Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
|---|---|---|---|---|---|---|---|---|---|
Patent 9944930 was granted and assigned to MiNA Therapeutics on April, 2018 by the United States Patent and Trademark Office. | 9944930 | April 17, 2018 | |||||||
Patent 9745579 was granted and assigned to MiNA Therapeutics on August, 2017 by the United States Patent and Trademark Office. | 9745579 | August 29, 2017 | |||||||
Patent 11365414 was granted and assigned to MiNA Therapeutics on June, 2022 by the United States Patent and Trademark Office. | 11365414 | June 21, 2022 | |||||||
Patent 11566246 was granted and assigned to MiNA Therapeutics on January, 2023 by the United States Patent and Trademark Office. | 11566246 | January 31, 2023 | |||||||
11447773 | September 20, 2022 | ||||||||
Patent 9885046 was granted and assigned to MiNA Therapeutics on February, 2018 by the United States Patent and Trademark Office. | 9885046 | February 6, 2018 | |||||||
10633659 | April 28, 2020 | ||||||||
Patent 10912790 was granted and assigned to MiNA Therapeutics on February, 2021 by the United States Patent and Trademark Office. | 10912790 | February 9, 2021 | |||||||
Patent 9284553 was granted and assigned to MiNA Therapeutics on March, 2016 by the United States Patent and Trademark Office. | 9284553 | March 15, 2016 | |||||||
Patent 8916534 was granted and assigned to MiNA Therapeutics on December, 2014 by the United States Patent and Trademark Office. | 8916534 | December 23, 2014 | |||||||
10704044 | July 7, 2020 | ||||||||
Patent 10202601 was granted and assigned to MiNA Therapeutics on February, 2019 by the United States Patent and Trademark Office. | 10202601 | February 12, 2019 | |||||||
10774331 | September 15, 2020 | ||||||||
Patent 8835400 was granted and assigned to MiNA Therapeutics on September, 2014 by the United States Patent and Trademark Office. | 8835400 | September 16, 2014 | |||||||
Patent 11162099 was granted and assigned to MiNA Therapeutics on November, 2021 by the United States Patent and Trademark Office. | 11162099 | November 2, 2021 | |||||||
Patent 11965163 was granted and assigned to MiNA Therapeutics on April, 2024 by the United States Patent and Trademark Office. | 11965163 | April 23, 2024 |